Quick Answer
LEMAITRE VASCULAR INC reported Gross Profit of $178.54 million for the year ending 2025.
- LEMAITRE VASCULAR INC showed an increase of +18.3% in Gross Profit from 2024 to 2025.
- This data is from LEMAITRE VASCULAR INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $13.12 million | Q2 2015: $13.13 million | Q3 2015: $13.52 million | Q4 2015: $14.40 million | Q1 2016: $14.36 million | Q2 2016: $15.37 million | Q3 2016: $17.02 million | Q4 2016: $16.19 million | Q1 2017: $17.35 million | Q2 2017: $17.52 million | Q3 2017: $17.58 million | Q4 2017: $18.25 million | Q1 2018: $18.47 million | Q2 2018: $18.99 million | Q3 2018: $17.26 million | Q4 2018: $19.22 million | Q1 2019: $19.46 million | Q2 2019: $20.32 million | Q3 2019: $20.17 million | Q4 2019: $19.91 million | Q1 2020: $20.48 million | Q2 2020: $17.03 million | Q3 2020: $22.70 million | Q4 2020: $24.40 million | Q1 2021: $23.80 million | Q2 2021: $26.76 million | Q3 2021: $24.87 million | Q4 2021: $25.96 million | Q1 2022: $25.96 million | Q2 2022: $27.81 million | Q3 2022: $25.07 million | Q4 2022: $26.05 million | Q1 2023: $30.88 million | Q2 2023: $32.09 million | Q3 2023: $30.82 million | Q4 2023: $33.27 million | Q1 2024: $36.67 million | Q2 2024: $38.47 million | Q3 2024: $37.18 million | Q1 2025: $41.42 million | Q2 2025: $44.97 million | Q3 2025: $45.96 million.
- Over the full 17 years of available data (2009 to 2025), LEMAITRE VASCULAR INC's Gross Profit has grown by 378.6%.
- Historical annual values: Fiscal year 2025: $178.54 million | Fiscal year 2024: $150.90 million | Fiscal year 2023: $127.05 million | Fiscal year 2022: $104.90 million | Fiscal year 2021: $101.38 million | Fiscal year 2020: $84.62 million | Fiscal year 2019: $79.85 million | Fiscal year 2018: $73.94 million | Fiscal year 2017: $70.70 million | Fiscal year 2016: $62.94 million | Fiscal year 2015: $54.17 million | Fiscal year 2014: $48.43 million | Fiscal year 2013: $45.12 million | Fiscal year 2012: $40.87 million | Fiscal year 2011: $40.23 million | Fiscal year 2010: $41.72 million | Fiscal year 2009: $37.30 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: